Clinical Data Management, Trends in US & The Emerging Markets. 

     Everyone associated with research today, clinical or basic, has to understand the concept of Clinical Data Management (CDM). CDM is a highly specialized branch that leads to generation of high quality, reliable, and statistically sound data from clinical trials and research studies. Why is that important?

Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for human use. Reproducibility of clinical research is absolutely essential and has to be submitted in the Summary of Clinical Efficacy Document to FDA for review before any drug/device gets approval for marketing.

Academic labs also have to adapt to more stringent data requirements. NIH now requires data sharing plans in large grants, statistical programming code and documentation.

AWIS NJ and Professional Science Master’s, Rutgers have invited a panel of experts to discussing current staus and emerging market trends about data management. Please click on the links below to get more information about the panelists:

 

Jacob Harel,

Founder

Harel Consulting

 

Benjamin Jackson  

Co-Founder, President and CEO

Quartesian

 

Tanya Chowdhury, CISA

Vice President, Audit, Compliance & Contracts

Quartesian

 

Vladimir Mats, PhD

Co-Founder, Vice President, Biostatistics

Quartesian

 

Flora Ma,

Senior Consultant

Harel Consulting

Soumitra Shankar Chowdhury, MBA

Co-Founder, Chief Operating Officer

Quartesian

Register Now!